INTRODUCTION {#s1}
============

Concern over antibiotic resistance is not a new topic. The European Union placed a ban on antibiotics in the mid 2000s ([@CIT0013]), the United States transitioned away from antibiotic use under the veterinary feed directive as of 1 January 2017 ([@CIT0030]), and only prescription use of medically important antimicrobials used for livestock will be allowed as of 1 December 2018 in Canada ([@CIT0015]). It is estimated that 90% of all weaned pigs have had exposure to antimicrobials at some point during production ([@CIT0031]; [@CIT0039]) and the weaning phase is the period of most likely exposure due to reduced disease resistance ([@CIT0009]). As a result, much emphasis is being placed on management and feeding strategies for weaned pigs in order to ensure optimal performance without the use of antibiotics ([@CIT0024]). [@CIT0024] suggested that a three-pronged approach that includes management, nutrition, and feed additives will be necessary to maintain performance at levels achieved prior to the removal of antibiotics.

Epidermal growth factor (**EGF**) is the most abundant growth factor in milk ([@CIT0025]) with receptors on the basolateral and luminal intestinal epithelial cells ([@CIT0017]) suggesting EGF is a suitable target feed additive to improve piglet health. We have previously demonstrated that a porcine EGF-secreting *Lactococcus lactis* increased weaned pig BW gain and feed efficiency and improved gut health through enhanced jejunal structure and reduced inflammatory index ([@CIT0003], [@CIT0002]). However, it is difficult to determine whether the degree of change in the intestinal structure is sufficient to account for the improvement in performance and thus another mechanism may also play a role in the observed response. It is generally acknowledged that intestinal microbiota play an important role in gut health and pig growth. Consequently, there has been a greater research emphasis placed on understanding the interaction between nutritional strategies, disease, overall animal health and the intestinal microbiota.

To further the application of EGF to production settings, we have recently generated a recombinant yeast that can produce porcine EGF at a concentration that is close to 10 times higher than that of *L. lactis* as a means to improve EGF production efficiency and reduce fermentation costs. The objectives of the study were to test the efficiency of the EGF-containing *Pichia pastoris* fermentation supernatant on weaned pig performance and to determine whether the positive influence on weight gain, efficiency, and gut health previously observed was related to differences in composition and functional capacity of the intestinal microbiota.

MATERIALS AND METHOD {#s2}
====================

The use of animals and all experimental procedures were approved by the University of Guelph's Animal Care Committee in accordance with the Canadian Council on Animal Care guidelines ([@CIT0005]).

Production of EGF Supernatant {#s3}
-----------------------------

The expression vector designed to express porcine EGF (pJ912-EGF) was codon-optimized for optimal expression in *P. pastoris* and synthesized by DNA2.0 (Menlo Park, CA). Plasmid DNA was linearized with *Swa*I (New England Biolabs; Beverly, MA) and purified by phenol-chloroform extraction and ethanol precipitation. Purified linearized plasmid DNA was dissolved in 10 µL of nuclease-free H~2~O. Electrocompetent *P. pastoris* X-33 (Invitrogen; Carlsbad, CA) was prepared according to the manufacturer's instructions. Competent cells (100 µL) were mixed with the dissolved purified DNA in a 0.4 cm gap width electroporation cuvette (BTX, San Diego, CA). Electroporation was carried out in an Electro Cell Manipulator 600 (BTX) at 1.5 kV. Transformed cells were plated on YPD agar (1% yeast extract (Difco, Detroit, MI), 2% peptone (Difco), 2% glucose (Fisher Scientific, Pittsburgh, PA, USA), 2% agar (Difco) supplemented with 1 M sorbitol and zeocin (100 µg/mL).

Positive transformant colonies were inoculated into a 500 mL flask containing 50 mL BMGY medium (1% yeast extract, 2% peptone, 100 mM potassium phosphate \[pH 6.0\], 1.4% yeast nitrogen base (Difco), 0.00004% biotin \[Difco), 1% glycerol (Fisher Scientific) at 30 °C with shaking at 250 rpm. For high cell density fermentation, *P. pastoris* cultivation was carried out in BioFlo/CelliGen 115 benchtop bioreactor (New Brunswick Scientific, Edison, NJ). Supernatant samples were harvested at 48 h of methanol induction of EGF expression. To quantify the EGF concentration, both indirect ELISA and western blot methods were employed and the EGF titer was 180 ± 30 mg/L ([Figure 1](#F1){ref-type="fig"}).

![Quantification of EGF secreted by *Pichia pastoris*. (A) Known concentrations of recombinant pig EGF were used to generate a standard curve to quantify EGF via indirect ELISA. (B) Western blot quantification of EGF in yeast supernatant (**SN**) after 28 h MeOH induction.](txy01901){#F1}

Western Blot and ELISA {#s4}
----------------------

Proteins in the fermentation supernatant were separated by 12% SDS-PAGE and then transferred to polyvinylidene difluoride (PVDF) membranes. After blocking in 5% skim milk at room temperature for 1 h, it was incubated with polyclonal rabbit primary antibody against pig EGF (1:1000 dilution; Biomatik, Cambridge, Ontario, Canada) at room temperature for 1 h. Membranes were then incubated in goat anti-rabbit IgG horseradish peroxidase-linked antibody (Cell Signaling Technology, Beverly, MA) at room temperature for 1 h, ECL Plus Western Blotting Detection System kit (Amersham, Piscataway, NJ) was used to detect EGF. The EGF level was also measured using Express ELISA kit for Rabbit Primary Antibodies (GenScript, Piscataway, NJ) according to manufacturer's instructions. Recombinant human EGF (Sigma Chemical Co., St. Louis, MO) was used as the standard and measured at 450 nm.

Animals, Diets, and Treatments {#s5}
------------------------------

A total of 72 pigs (two equal blocks of 36 pigs with three barrows and three gilts/pen) at 6.64 ± 0.29 kg BW were assigned to one of two dietary treatments at weaning (20 ± 2 d of age; *n* = 6 pens/treatment) balancing across treatment for litter, gender, and initial BW. Dietary treatments consisted of *P. pastoris* fermentation supernatant with EGF (**EGF-PP**) and *P. pastoris* fermentation supernatant without EGF (control). Supplementation of fermentation supernatant with or without EGF were included in phases I and II of a three-phase feeding program ([Table 1](#T1){ref-type="table"}), where phase I was fed for 1 wk and phase II for 2 wk. Based on previous work ([@CIT0003], [@CIT0002]), EGF supplementation is expected to stimulate intestinal development, thus a common phase III diet was provided to all pigs for one additional week to determine if the expected benefit lasted after EGF was withdrawn. Diets were formulated to meet or exceed [@CIT0041] nutrient requirements for weaned pigs. Pigs in the EGF-PP group were given volumes of the fermentation product to achieve 120 µg EGF-containing supernatant/kg BW per day, based on analyzed EGF concentrations in the supernatant. The EGF calculation was based on the initial BW, BW-week 1, and BW-week 2 for entire wk 1, wk 2, and wk 3, respectively. The EGF concentration required in the supernatant per pen was prepared in a total volume of 50 mL and mixed with the feed before being fed. Control pigs were fed matching volumes of fermentation supernatant of *P. pastoris* without EGF. The fermentation products were mixed in with fresh feed at 9:00 a.m. daily and feed was replenished throughout the day. Feed refusals were removed weekly and weighed for determination of pen feed disappearance. Pigs had ad libitum access to feed and water.

###### 

Ingredient composition (as-fed) and nutrient analysis of a three-phase feeding program for newly weaned pigs supplemented with EGF\*

  Item                               Phase I    Phase II   Phase III
  ---------------------------------- ---------- ---------- -----------
  Ingredients (%)                                          
   Wheat                             20.25      20.20      15.00
   Corn                              14.52      26.23      48.85
   Oat groats                        7.50       5.00       ---
   Fish meal                         7.50       5.00       ---
   Soybean meal, dehulled (48% CP)   20.00      25.00      30.00
   Soy protein concentrate           2.50       ---        ---
   Whey                              20.80      12.85      ---
   Lys-HCl                           0.28       0.34       0.35
   DL-methionine                     0.17       0.18       0.12
   Threonine                         0.14       0.16       0.14
   Tryptophan                        0.01       0.01       ---
   Limestone                         0.75       0.90       1.17
   Monocalcium phosphate             0.48       0.88       0.97
   Salt                              0.10       0.25       0.40
   AV fat blend/tallow               4.50       2.50       2.50
   Vitamin and mineral mix^†^        0.50       0.50       0.50
  Calculated nutrient content                              
   DE (kcal/kg)                      3,654.34   3,534.92   3,530.14
   CP, %                             24.39      23.20      21.04
   Total Lys, %                      1.67       1.57       1.35
   SID Lys, %                        1.51       1.42       1.22
   Ca, %                             0.78       0.79       0.72
   P, %                              0.69       0.71       0.61
   Dig. P, %                         0.38       0.38       0.28
  Analyzed nutrient content                                
   DM, %                             87.56      86.63      86.96
   CP, %                             22.58      21.79      20.36
   Ca, %                             0.85       0.83       0.73
   P, %                              0.74       0.72       0.63

\*Phases I and II diets were fed for 7 and 14 d post-weaning, respectively, and supplemented with either *Pichia pastoris* fermentation supernatant containing EGF or *P. pastoris* fermentation supernatant without EGF. All pigs received a common Phase III diet for 7 d.

^†^Supplied per kg of complete diet: vitamin A, 10,000 IU in the form of retinyl acetate (2.5 mg) and retinyl palmitate (1.7 mg); vitamin D, 1,000 IU in the form of cholecalciferol; vitamin E, 56 IU in the form of DL-α-tocopherol acetate (44 mg);vitamin K, 2.5 mg in the form of menadione; choline, 500 mg; pantothenic acid,15 mg; riboflavin, 5 mg; folic acid, 2 mg; niacin, 25 mg; thiamine, 1.5 mg; vitamin B-6, 1.5 mg; biotin, 0.2 mg; vitamin B-12, 0.025 mg; Se, 0.3 mg in the form of Na~2~SeO~3~; Cu, 15 mg in the form of CuSO~4~5H~2~O; Zn, 104 mg in the form of ZnO; Fe, 100 mg in the form of FeSO~4~; Mn, 19 mg in the form of MnO~2~; and I, 0.3 mg in the form of KI 2.

Animal Performance and Sample Collection {#s6}
----------------------------------------

Pigs were weighed individually at the end of each week to determine ADG and weekly feed disappearance was determined to calculated ADFI. Feed efficiency as G:F was calculated from daily gain over daily intake. Previous studies indicated a positive response to EGF in the small intestine ([@CIT0003]; [@CIT0002]); because the ileum has greater concentrations of microbial populations than more proximal small intestine sections ([@CIT0014]), thus microbial populations in the ileum were evaluated. On day 21 post-weaning, one pig from each pen with a BW closest to the pen average was euthanized using an intracardial injection of pentobarbital sodium and phenytoin sodium (Euthansol, 0.3 mL/kg BW; Intervet Canada Corp., Kirkland, Quebec, Canada) for collection of ileal digesta and subsequent microbial composition analyses. The visceral cavity was opened for removal of the small intestine; the ileum was clamped at each end prior to removal to avoid spilling of digesta. The ileal digesta contents were collected in sterile tubes and kept on ice until being stored at −80 °C until further use.

Microbial Assessment {#s7}
--------------------

### DNA extraction. {#s8}

Approximately 200 mg of each digesta sample (*n* = 6 per treatment group) was used for genomic DNA extraction using ZR Fecal DNA MiniPrep (ZYMO Research, Irvine, CA), which included a bead-beating step for the mechanical lysis of the microbial cells. DNA was quantified using a NanoDrop 2000 spectrophotometer (Thermo Scientific, Waltham, MA). DNA samples were normalized to 20 ng/µL, and quality checked by PCR amplification of the 16S rRNA gene using universal primers 27F (5′-GAAGAGTTTGATCATGGCTCAG-3′) and 342R (5′-CTGCTGCCTCCCGTAG-3′) as described ([@CIT0036]). Amplicons were verified by agarose gel electrophoresis.

### Library construction and illumina sequencing. {#s9}

The V4 region of 16S rRNA gene was targeted for PCR amplification using a modified F338 and barcoded R806 primers ([@CIT0008]) as described previously ([@CIT0040]). PCR reactions were performed in duplicate for each sample and contained 1.0 µL of prenormalized DNA, 1.0 µL of each forward and reverse primers (10 µM), 12 µL HPLC grade water (Fisher Scientific, Ottawa, Ontario, Canada), and 10 µL 5 Prime Hot MasterMix (5 Prime, Inc., Gaithersburg, MD). Reactions consisted of an initial denaturing step at 94 °C for 3 min followed by 30 amplification cycles at 94 °C for 45 s, 62 °C for 60 s, and 72 °C for 90 s; finalized by an extension step at 72 °C for 10 min in an Eppendorf Mastercycler pro (Eppendorf, Hamburg, Germany). PCR products were then purified using a ZR-96 DNA Clean-up Kit (ZYMO Research) to remove primers, deoxy-nucleotide-tri phosphates (dNTPs) and reaction components. The V4 library was then generated by pooling 200 ng of each sample, quantified by PicoGreen dsDNA (Invitrogen, Burlington, Ontario, Canada) and diluted to a final concentration of 5 pM, measured by Qubit 2.0 Fluorometer (Life technologies, Burlington, Ontario, Canada). To improve the unbalanced and biased base composition of the generated 16S rRNA gene libraries, 15% of PhiX control library was spiked into each amplicon pool. Customized sequencing primers for read 1 (5′-TATGGTAATTGTGTG CCAGCMGCCGCGGTAA-3′), read 2 (5′-AGTCAGTCAGCCGGAC TACHVGGG TWTCTAAT-3′), and index read (5′-ATTAGAWACCCBDGTA GTCCGGCTGA CTGACT-3′) were synthesized and purified by polyacrylamide gel electrophoresis (Integrated DNA Technologies, Coralville, IA) and added to the MiSeq Reagent Kit v3 (600-cycle; Illumina, San Diego, CA). The 300 paired-end sequencing reaction was performed on a MiSeq platform (Illumina) at the Gut Microbiome and Large Animal Biosecurity Laboratories, Department of Animal Science, University of Manitoba, Canada. All sequencing data are uploaded into the Sequence Read Archive of NCBI and are available through accession numbers SRR6491189-98.

### Bioinformatic analysis. {#s10}

The FLASH assembler ([@CIT0022]) was used to merge overlapping paired-end Illumina FASTQ files. Sequences with mismatches or ambiguous calls in the overlapping region were discarded. The output FASTQ file was then analyzed by downstream computational pipelines of the open source software package QIIME version 1.9.1 ([@CIT0007]). Assembled reads were demultiplexed according to the barcode sequences and exposed to additional quality-filters so that reads with ambiguous calls and those with phred quality scores (Q-scores) below 20 were discarded. Chimeric reads were filtered using UCHIME ([@CIT0012]) and sequences were assigned to operational taxonomic units (**OTU**) using the QIIME implementation of UCLUST ([@CIT0011]) at 97% pairwise identity threshold. Taxonomies were assigned to the representative sequence of each OTU using RDP classifier ([@CIT0033]) and aligned with the Greengenes Core reference database ([@CIT0010]) using PyNAST algorithms ([@CIT0006]).The phylogenetic tree was built with FastTree 2.1.3. ([@CIT0028]) for further comparisons between microbial communities.

Within-community diversity (alpha-diversity) was calculated by different indices of species richness and evenness including Shannon, Simpson, Chao1, observed number of species, goods coverage, and PD whole tree using the open source software QIIME. An even depth of 15,140 sequences per sample was used to calculate the richness and diversity indices for the ileal digesta, respectively. Beta-diversity was measured by calculating the weighted and unweighted UniFrac distances ([@CIT0021]) using QIIME default scripts. Principal coordinate analysis was applied on resulting distance matrices to generated two-dimensional plots using PRIMER 7 software ([@CIT0043]).

The open source software, Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (**PICRUSt**, version 1.0.0) was used to predict metagenome function based on 16S rRNA gene sequences ([@CIT0019]). For the PICRUSt analysis, closed-reference OTUs were picked at 97% similarity against the Greengenes database. The OTUs were normalized for predicted 16S rRNA copy number before predicting gene family abundance for each metagenome based on Kyoto Encyclopedia of Genes and Genomes (**KEGG**) orthology groups (**KO**s) using [@CIT0019]. The correlation plot was generated by R (3.3.1 version) with the corrplot package ([@CIT0034]).

Statistical Analysis {#s11}
--------------------

Statistical analyses of the BW, daily gain, daily intake, and G:F data were performed using PROC MIXED and repeated measures analysis in SAS version 9.4 (SAS Inst. Inc., Cary, NC) with pen as the experimental unit and the main effect of diet, week, and diet by week interaction. Differences in alpha-diversity indices among treatment groups were calculated using GLIMMIX procedure (Tukey studentized range adjustment) with EGF-PP supplementation as fixed-effect and individual animal as random the variable. Permutational multivariate analysis of variance (**PERMANOVA**, Primer 7; [@CIT0001]) was used to calculate *P* values of UniFrac distances between EGF and control groups. Multivariate Association with Linear Models (**MaAsLin**) combined with GLIMMIX model analysis was used to analyze the difference in relative abundance of bacterial taxa at the phylum and genus levels between EGF-PP and control. Welch's *t*-test was applied on gene function from PICRUSt outputs, percentage of the predicted metagenome made by a given KEGG functional module, using STAMP 2.0 to compare differences in functional capacity of microbiome between treatment groups. Correlations between bacterial taxa and growth performances were calculated by nonparametric Spearman's rank correlation analysis using Prism 7. The differences between treatment groups were considered significant at *P* \< 0.05.

RESULTS AND DISCUSSION {#s12}
======================

Growth Performance {#s13}
------------------

Pigs fed diets containing EGF-PP were heavier (*P* \< 0.04) at days 21 and 28 post wean, due to improved (*P* = 0.0002) daily gain and G:F in week 3 and no difference in feed disappearance ([Table 2](#T2){ref-type="table"}). BW, daily gain, and feed intake increased (*P* \< 0.0001) with week post-wean ([Table 2](#T2){ref-type="table"}). There was an interaction between diet and week for daily gain. In control-fed pigs, daily gain increased (*P* \< 0.001) on a weekly basis up to week 3 followed by a plateau in week 4. Alternatively, in EGF-PP fed pigs, gain increased (*P* \< 0.0001) weekly up to week 3 followed by a decrease (*P* = 0.0005) in gain in week 4. Overall G:F was greater (*P* = 0.033) in pigs fed diets containing EGF-PP (0.695 vs. 0.639 ± 0.018). Despite the slight decrease in daily gain from weeks 3 to 4 in pigs fed EGF-PP, daily gain was equivalent in week 4 between groups, such that pigs fed EGF-PP remained 1 kg heavier at day 28. Feed additives targeted for improvement of gut health beyond the stomach must be retained through to the site of desired action, such as the small intestine in this study, in order to have an impact. [@CIT0037] confirmed the presence of EGF in intestinal digesta following a period of EGF feeding. The improvement in growth performance is similar to that previously reported using EGF supernatant produced using *L. lactis* ([@CIT0002]) indicating retained efficacy of the recombinant EGF using a yeast-based production system. In addition, the control group similarly received *P. pastoris* fermentation broth; thus, the improved performance is due to EGF rather than potential active compounds supplied by the fermentation supernatant.

###### 

Growth performance of weaned pigs fed diets with or without EGF supernatant\*

  Item                     Treatment   SEM^†^     *P* value^†^                      
  ------------------------ ----------- ---------- -------------- ------- ---------- -------
  BW, kg                                          0.26           0.029   \<0.0001   0.067
   Weaning                 6.68        6.59                                         
   Day 7                   7.43        7.33                                         
   Day 14                  9.39        9.48                                         
   Day 21                  13.44^a^    14.27^b^                                     
   Day 28                  17.30^a^    18.38^b^                                     
  Daily gain, g/d                                 17             0.002   \<0.0001   0.044
   Week 1                  103         105                                          
   Week 2                  282         307                                          
   Week 3                  578^a^      676^b^                                       
   Week 4                  552         585                                          
  Daily feed intake, g/d                          33             0.449   \<0.0001   0.604
   Week 1                  185         185                                          
   Week 2                  351         348                                          
   Week 3                  766         768                                          
   Week 4                  1,292       1,366                                        
  G:F, g/g                                        0.04           0.033   \<0.0001   0.319
   Week 1                  0.56        0.58                                         
   Week 2                  0.81        0.88                                         
   Week 3                  0.75^a^     0.88^b^                                      
   Week 4                  0.43        0.43                                         

\*Phases I and II diets were fed for 7 and 14 d post-weaning, respectively, and supplemented with either *Pichia pastoris* fermentation supernatant containing EGF or *P. pastoris* fermentation supernatant without EGF (control). All pigs received a common phase III diet for 7 d.

^†^Data were analyzed as repeated measures. SEM represents SE for treatment \* week lsmeans. Within a row, values with different superscript ^a,b^ differ *P* \< 0.05.

Microbiota Analysis {#s14}
-------------------

A total of 11 ileum digesta samples were bioinformatically analyzed. One of the control samples was eliminated from bioinformatics analyses due to low sequence reads. In total, 393,964 sequences were generated with an average of 35,815 sequences per sample. There was no difference in alpha-diversity of digesta samples between pigs fed diets containing EGF-PP or control ([Table 3](#T3){ref-type="table"}). Similarly, there was no separation among microbiota based on weighted and unweighted beta-diversity ([Figure 2](#F2){ref-type="fig"}). There was no effect of EGF supernatant on relative abundances of bacteria phyla in the ileal digesta ([Table 4](#T4){ref-type="table"}). Firmicutes made up the dominant phyla in both groups representing 99.9 and 99.1 ± 0.8% of the community in pigs fed EGF-PP and control diets, respectively. *Lactobacillus* (88.3 and 83.8 ± 15.2%), *Streptococcus* (0.33 and 12.8 ± 10.3%), *Clostridium* (1.3 and 0.4 ± 0.6%), *Sarcina* (4.0 and 0.27 ± 3.3%) were the primary genera within the EGF-PP and control-fed pigs. The remaining 6% and 2% consisted of genera representing \<1% relative abundance of the community ([Table 4](#T4){ref-type="table"}). There were four bacterial taxa whose relative abundances were higher (*P* \< 0.05) in control-fed pigs compared to the EGF group (*Corynebacterium, Blautia, and Coprococcus* genus and Ruminococcaceae family) with each representing 0.10, 0.30, 0.06, and 0.05 %, respectively, of the community ([Figure 3](#F3){ref-type="fig"}). In a longitudinal analysis of fecal bacterial populations in commercial swine herds, *Blautia* and *Coprococcus* were identified as part of the common intestinal bacterial community, present at abundances \<5% declining in abundance with age ([@CIT0018]). Species within the *Corynebacterium* (i.e. *C. diptherium*) have been associated with intestinal disease in humans and pigs ([@CIT0027]; [@CIT0004]). Grow-finish pigs fed diets containing resistant starch had greater relative proportions of *Coprococcus* and *Blautia* in the cecum and colon that were positively correlated with carbohydrate metabolism ([@CIT0029]). Digesta samples in the current study were collected at the end of phase II which represents proportional changes in diet ingredients that have been previously associated with impacting gut microbiota ([@CIT0020]). Thus, changes in microbial populations due to diet ingredients, which would be expected to be consistent across treatments due to the same base diet being fed, may have masked the impact of EGF supplementation which may be acting through direct contact with luminal bacteria (although less likely) or indirectly through improvement in overall intestinal health.

###### 

Alpha-diversity indices of ileal digesta from weaned pigs fed diets supplemented *Pichia pastoris* fermentation supernatant with or without EGF\*

  Item               EGF      Control   Pooled SEM   *P* value
  ------------------ -------- --------- ------------ -----------
  Shannon            3.35     3.37      0.28         0.95
  Simpson            0.76     0.76      0.05         0.96
  Observed species   421.2    429.4     44.8         0.90
  Chao 1             1151.6   1050.8    99.84        0.49
  Goods coverage     0.98     0.98      0.001        0.84
  PD whole tree      7.15     11.30     2.45         0.26

\*Diets were supplemented with the respective *P. pastoris* fermentation supernatant in phase I (days 0 to 7) and phase II (days 8 to 21). All pigs received a common diet in phase III (days 22 to 28). Ileal digesta was collected on day 28 post-wean.

###### 

Relative abundance of bacterial taxa in ileal digesta from weaned pigs fed diets supplemented *Pichia pastoris* fermentation supernatant with or without EGF\*

  Taxa                                    EGF        Control    Pooled SEM   *P* value
  --------------------------------------- ---------- ---------- ------------ -----------
  p\. Actinobacteria                      0.042      0.736      0.43         0.29
     g. *Actinomyces*                     0.010      0.222      0.09         0.24
    f. Actinosynnemataceae unclassified   0.003      0.028      0.12         0.56
     g. *Corynebacterium*                 0.000^a^   0.086^b^   0.03         0.02
    f. Micrococcaceae unclassified        0.004      0.178      0.05         0.22
     g. *Saccharopolyspora*               0.001      0.024      0.02         0.44
     g. *Streptomyces*                    0.003      0.098      0.04         0.35
     g. *Bifidobacterium*                 0.018      0.045      0.03         0.71
  p\. Bacteroidetes                       0.007      0.044      0.03         0.32
     g. *Prevotella*                      0.004      0.034      0.03         0.99
  p\. Cyanobacteria                       0.001      0.041      0.04         0.31
   o. Streptophyta unclassified           0.001      0.038      0.03         0.31
  p\. Firmicutes                          99.94      99.08      0.77         0.29
   o. Bacillales unclassified             0.001      0.151      0.04         0.44
    f. Gemellaceae unclassified           0.001      0.037      0.03         0.11
     g. *Lactobacillus*                   88.30      83.80      15.21        0.77
     g. *Weissella*                       0.000      0.025      0.02         0.30
     g. *Lactococcus*                     0.012      0.638      0.57         0.30
     g. *Streptococcus*                   0.331      12.77      10.27        0.26
   o. Clostridiales unclassified          0.000      0.025      0.02         0.27
    f. Clostridiaceae unclassified 1      5.771      0.423      4.39         0.26
     g. *Clostridium*                     1.278      0.036      0.06         0.92
     g. *Sarcina*                         4.048      0.272      3.28         0.28
    f. Clostridiaceae unclassified 2      0.129      0.009      0.10         0.25
    f. Lachnospiraceae unclassified       0.011      0.114      0.06         0.26
     g. *\[Ruminococcus\]*                0.001      0.046      0.02         0.17
     g. *Blautia*                         0.003^a^   0.262^b^   0.03         0.003
     g. *Coprococcus*                     0.000^a^   0.055^b^   0.02         0.003
     g. *Dorea*                           0.001      0.028      0.02         0.17
     g. *Peptostreptococcus*              0.001      0.040      0.02         0.44
    f. Ruminococcaceae unclassified       0.001^a^   0.078^b^   0.03         0.02
     g. *Megasphaera*                     0.009      0.030      0.03         0.44
     g. *Veillonella*                     0.010      0.017      0.01         0.46
     g. *\[Eubacterium\]*                 0.003      0.034      0.02         0.20
     g. *Catenibacterium*                 0.001      0.024      0.02         0.44

\*The table shows the relative abundance of bacterial taxa at genus level (above 0.01%); some taxa could only be classified to family (f), order (o) or class (c) level. Within a row, values with different superscript ^a,b^ differ *P* \< 0.05.

![Principal coordinates analysis (**PCoA**) plots of unweighted (A) and weighted (B) UniFrac distances of microbiota of ileal digesta samples from pigs fed diets supplemented with either *Pichia pastoris* fermentation supernatant containing EGF or *P. pastoris* fermentation supernatant without EGF (control). For each comparison, the *P* value was obtained from PERMANOVA and considered significant for *P* \<0.05.](txy01902){#F2}

![Relative abundance of bacterial taxa in ileal digesta that significantly differed from pigs fed diets supplemented with either *Pichia pastoris* fermentation supernatant containing EGF or *P. pastoris* fermentation supernatant without EGF (control). Values are presented as least square means with SEM. \**P* \< 0.05; \*\**P* \< 0.01.](txy01903){#F3}

In the current study, presence of these four taxa were generally negatively associated with performance ([Figure 4](#F4){ref-type="fig"}). Specifically, *Coprococcus, Corynebacterium,* and *Blautia* were negatively associated with BW in week 4 (*P* \< 0.05). *Coprococcus* and *Corynebacterium* were also negatively associated with BW in week 3 (*P* \< 0.05) and Ruminococcaceae was negatively correlated with feed disappearance (*P* \< 0.05). While there did appear to be a relationship between minor changes in gut bacterial populations and performance, interpretation of correlation data, particularly given the very low abundance of these bacteria, should be made cautiously.

![Correlation between pig growth performances and relative abundance of the four ileal bacterial taxa including *Corynebacterium, Blautia, Coprococcus*, and Ruminococcaceae. The scale colors (Spearman's *ρ* from −1 to +1) indicate whether the correlation is positive (blue colored circle) or negative (red colored circle) between the taxa and growth performances. The \* symbol indicates a statistically significant correlation at *P* \<0.05. iBW, BW.weeks 1, 2, 3, and 4 represent BW on days 0, 7, 14 and 28; daily gain (DG); weeks 1, 2, 3, 4 and overall represent ADG in weeks 1, 2, 3, 4, and all 4 weeks. Similarly, daily feed disappearance (DFD) weeks 1, 2, 3, 4, and overall and GF.weeks 1, 2, 3, 4, and overall represent average daily feed disappearance and G:F in weeks 1, 2, 3, 4, and all 4 weeks.](txy01904){#F4}

Prediction of Functional and Metabolic Capacity of Ileal Microbiota {#s15}
-------------------------------------------------------------------

A total of 328 level 3 KEGG pathways were predicted in the microbiome of the ileum digesta samples ([Supplementary Table 2](#sup1){ref-type="supplementary-material"}). Of these, four metabolic pathways were different (*P* \< 0.05) between treatment groups ([Figure 5](#F5){ref-type="fig"}). In pigs fed EGF-PP containing diets, the inositol phosphate metabolism, retinol metabolism, and drug and xenobiotics metabolism related to cytochrome P450 expression were underrepresented compared to the control. The role of these four pathways in explaining the observed growth performance is unclear. Inositol phosphates play a role in regulating cell proliferation and migration. [@CIT0042] reported EGF-stimulated inositol triphosphate formation in cells overexpressing the EGF-receptor which appears opposite of the under-representation of inositol phosphate metabolic pathway in pigs fed EGF-containing diets in the current study. Alternatively, cytochromes P450 are involved in elimination of foreign chemicals from the body, as well as, the metabolism and inactivation of drugs. They are also required for metabolic activation of derivatives that can cause toxicity and cell death ([@CIT0035]). The lower predicted representation of drug and xenobiotic metabolism by cytochrome P450 may represent a positive gut metabolic shift. In an in vitro analysis, [@CIT0038] reported suppressed expression of constitutive cytochrome P450 2C11 mRNA in rat hepatocytes incubated with EGF.

![Fold change in the number of 16S rRNA sequences annotated to hierarchy level 3 KEGG pathways representing the predicted metabolic capacity of the ileum microbiome with significant differences (*P* \< 0.05) between EGF and control. Weaned pigs were fed diets supplemented with either *Pichia pastoris* fermentation supernatant containing EGF or *P. pastoris* fermentation supernatant without EGF (control).](txy01905){#F5}

Production of EGF using a recombinant yeast improved weaned pig performance. The effects of EGF on intestinal health (and thus pig growth) may be loosely associated with the metabolic functional capacity of the gut microbiota rather than dramatic changes in the bacterial populations themselves. However, the impact on mucosa-associated bacteria or large intestinal bacterial populations is unknown.
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======================
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Click here for additional data file.
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